https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/731369 Tue, 19 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731369-sec-looks-to-reforms-to-make-ipos-great-again http://www.bioworld.com/articles/731229 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731229-kaileras-record-ipo-headlines-strong-april-for-biopharma-financings Financial markets rebound illustration http://www.bioworld.com/articles/731228 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731228-follow-ons-hit-7-year-high-lead-med-techs-10b-start-to-2026 Dollar sign thermometer http://www.bioworld.com/articles/731227 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731227-china-med-tech-raises-star-sports-105m-ipo-cofoe-nabs-133m ​Star Sports Medicine HKEX IPO ceremony Star Sports Medicine's IPO ceremony on May 5. Credit: HKEX; x.com – @HKEXGroup http://www.bioworld.com/articles/731048 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731048-metis-techbio-impact-tx-cleared-for-hong-kong-ipos Businessman and IPO virtual screen http://www.bioworld.com/articles/730985 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730985-follow-ons-hit-7-year-high-lead-med-techs-10b-start-to-2026 Dollar sign thermometer http://www.bioworld.com/articles/730982 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730982-mobia-debuts-on-nasdaq-to-bring-stroke-therapy-to-more-patients Mobia Medical Vivistim system Vivistim Paired VNS system. Credit: Mobia Medical Inc. http://www.bioworld.com/articles/730980 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730980-odysseys-ipo-placement-brings-304m-to-lead-drugs-in-ibd-lupus IPO, coins, financial chart http://www.bioworld.com/articles/730868 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730868-china-med-tech-raises-star-sports-105m-ipo-cofoe-nabs-133m ​Star Sports Medicine HKEX IPO ceremony Star Sports Medicine's IPO ceremony on May 5. Credit: HKEX; x.com – @HKEXGroup http://www.bioworld.com/articles/730866 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730866-kaileras-record-ipo-headlines-strong-april-for-biopharma-financings Financial markets rebound illustration http://www.bioworld.com/articles/730865 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730865-swiss-biotech-reports-record-private-investment-employment-in-2025 Swiss currency http://www.bioworld.com/articles/730765 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730765-hemab-prices-301m-in-latest-upsized-biopharma-ipo IPO and digital hologram with business icons http://www.bioworld.com/articles/730764 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730764-seaport-joins-nasdaq-as-parent-puretech-delists-sticks-with-lse Stock exchange board http://www.bioworld.com/articles/730746 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730746-mists-of-avalyn-thicken-with-300m-ipo-for-inhaled-drugs Going public ticker http://www.bioworld.com/articles/730785 Tue, 28 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730785-ribo-diagens-tally-2-hong-kong-biotech-medtech-ipos-in-q1-2026 Hong Kong stock market illustration http://www.bioworld.com/articles/730619 Fri, 24 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730619-ribo-diagens-tally-2-hong-kong-biotech-medtech-ipos-in-q1-2026 Hong Kong stock market illustration http://www.bioworld.com/articles/730578 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730578-mabwell-turns-to-hong-kong-to-fund-adc-ambitions HKEX exterior Credit: Lewis Tse Pui Lung - stock.adobe.com http://www.bioworld.com/articles/730573 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730573-med-tech-financings-steady-at-88b-in-q1-despite-volume-drop Layered charts http://www.bioworld.com/articles/730409 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730409-mabwell-turns-to-hong-kong-to-fund-adc-ambitions HKEX exterior Credit: Lewis Tse Pui Lung - stock.adobe.com BioWorld data.]]> http://www.bioworld.com/articles/730403 Fri, 17 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730403-obesity-focused-kailera-goes-for-us-biopharma-record-with-625m-ipo Gold IPO with chart http://www.bioworld.com/articles/730396 Thu, 16 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730396-med-tech-financings-steady-at-88b-in-q1-despite-volume-drop Layered charts http://www.bioworld.com/articles/730210 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730210-ipo-market-strengthens-in-q1-2026-as-biopharma-financings-reach-2282b Virtual IPO word with stock graph and arrow http://www.bioworld.com/articles/730138 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730138-vc-activity-drives-march-med-tech-financings-to-24b Hand holding smartphone with dollar sign, arrows hovering http://www.bioworld.com/articles/730235 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730235-biopharma-financings-nearly-double-vs-2025-to-251b Gray and green glass dollar symbols with arrow pointing up http://www.bioworld.com/articles/730119 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730119-biopharma-financings-nearly-double-vs-2025-to-251b Gray and green glass dollar symbols with arrow pointing up http://www.bioworld.com/articles/729897 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729897-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729763 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729763-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729715 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729715-kanaphs-27m-ipo-to-aid-multi-modality-cancer-immune-portfolio Lee Byoung-chul, CEO, Kanaph Kanaph CEO Lee Byoung-chul at the company's IPO ceremony. http://www.bioworld.com/articles/729714 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729714-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics http://www.bioworld.com/articles/729533 Mon, 16 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729533-kanaphs-27m-ipo-to-aid-multi-modality-cancer-immune-portfolio Lee Byoung-chul, CEO, Kanaph Kanaph CEO Lee Byoung-chul at the company's IPO ceremony.